Less than 1 in 5 US Adults Meeting Heart Health Goals, According to AHA Scientific Statement
January 17, 2022

Available therapies combined with new approaches that address social determinants of health and other barriers to care can help, suggests new statement.

Certain Cardiovascular Conditions, Risks May be Worse for Cognition in Middle-aged Women
January 06, 2022

A Mayo Clinic study found certain cardiovascular conditions and risk factors are more strongly associated with cognitive decline in middle-aged women than men.

Smoking Outcomes May Improve ASCVD Risk Prediction, Suggests New Analysis
December 14, 2021

In a new retrospective analysis, including smoking history in the 2013 ACC/AHA pooled cohort equations significantly improved ASCVD risk prediction.

Persistent Dyspnea in Patients with Long COVID-19 May Indicate Heart Issues
December 13, 2021

New research presented at EuroEcho 2021 may help explain why some patients with long COVID-19 experience persistent dyspnea even 1 year after recovery.

CARDIOLOGY: 2021 Clinical Focus Collection
December 10, 2021

AHA Scientific Sessions 2021 recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.

12 Drugs Approved for Primary Care in 2021
December 08, 2021

Get a quick look at 12 of the many FDA-approved drugs in 2021 for conditions commonly seen in primary care.

Blood Pressure Control Worsened among US Adults during Pandemic, Suggests New Study
December 06, 2021

Women and older adults had the highest increases in blood pressure levels during the pandemic, according to new research.

Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials
November 18, 2021

AHA 2021: New research showed MK-0616, an investigative oral PCSK9 inhibitor, was associated with a near 65% decrease in LDL-C.

Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients
November 16, 2021

AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.

Gregory Marcus, MD, MAS, Reviews the Coffee and Real-time Atrial & Ventricular Ectopy (CRAVE) Trial
November 15, 2021

AHA 2021: Marcus, lead author of CRAVE, says it found little effect of caffeine on atrial arrhythmias, a significant effect on PVCs, a negative effect on sleep, and a boosting effect on physical activity.